Platform Therapeutics, Inc.
Andover, MA ยท Biotechnology
Platform Therapeutics, Inc. is a biotechnology company based in Andover, Massachusetts. In a Form D filed with the SEC on August 27, 2026, it reported raising $1,750,000 from 1 investor as part of an offering of up to $4,000,000. The first sale in the offering took place on August 12, 2026.
- Amount raised
- $1,750,000
- Offering size
- $4,000,000
- Investors so far
- 1
- First sale
- August 12, 2026
- Securities offered
- Equity
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Andover, Massachusetts
- Incorporated
- Delaware, 2022
- Entity type
- Corporation
- Revenue range
- Not Applicable
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $1,750,000 | $4,000,000 | 1 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Other health care raises in Massachusetts
| Company | Location | Sector | Raised | Target | Filed |
|---|---|---|---|---|---|
| Axelyf, Inc. | Chestnut Hill, MA | Health Care | $2.6M | $2.7M | |
| Soterya, Inc. | Boston, MA | Health Care | $850K | $2M | |
| Bioventrix, Inc. | Mansfield, MA | Health Care | $1.2M | $3M | |
| Opus KSD, Inc. | Pembroke, MA | Health Care | $681K | $681K | |
| Xact Bio, Inc. | Boston, MA | Health Care | $10M | $18M | |
| Way Biosolutions, Inc. | Cambridge, MA | Health Care | $2M | $2M |